Clinical Trial Supply and Logistics

Clinical Trial Supply and Logistics

Global Clinical Trial Supply and Logistics Market to Reach US$5.2 Billion by 2030

The global market for Clinical Trial Supply and Logistics estimated at US$3.6 Billion in the year 2023, is expected to reach US$5.2 Billion by 2030, growing at a CAGR of 5.5% over the analysis period 2023-2030. Logistics & Distribution Services, one of the segments analyzed in the report, is expected to record a 6.0% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Comparator Sourcing Services segment is estimated at 5.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$978.0 Million While China is Forecast to Grow at 9.0% CAGR

The Clinical Trial Supply and Logistics market in the U.S. is estimated at US$978.0 Million in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$1.1 Billion by the year 2030 trailing a CAGR of 9.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.2% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.4% CAGR.

Global Clinical Trial Supply and Logistics Market - Key Trends and Drivers Summarized

Clinical trial supply and logistics play a critical role in the successful execution of clinical research. This specialized field encompasses the sourcing, management, and distribution of investigational products, as well as the necessary equipment and ancillary supplies to clinical trial sites. Ensuring that these components are delivered on time, in the right condition, and in compliance with regulatory standards is paramount to maintaining the integrity of the clinical trial process. This intricate logistics network involves coordination between pharmaceutical companies, contract research organizations (CROs), and various supply chain partners, each contributing to the seamless operation of clinical trials across multiple regions.

Recent advancements in clinical trial supply and logistics are significantly enhancing efficiency and reliability. Technology integration, such as real-time tracking and monitoring systems, has improved the visibility and management of supply chains, enabling stakeholders to track shipments accurately and respond swiftly to any issues that arise. Innovations in packaging and cold chain logistics are also crucial, particularly for biologics and other temperature-sensitive products that require stringent storage conditions. Additionally, the use of blockchain technology is emerging as a transformative tool for ensuring data integrity and traceability throughout the supply chain, thus enhancing transparency and security in clinical trial operations.

The growth in the clinical trial supply and logistics market is driven by several factors. Firstly, the increasing complexity and globalization of clinical trials necessitate robust logistics solutions to manage multi-site studies and diverse regulatory environments. Secondly, the rise in biologics and personalized medicine, which often require specialized handling and storage, is propelling demand for advanced logistics capabilities. Furthermore, technological advancements such as real-time tracking, AI-driven predictive analytics, and blockchain are revolutionizing the supply chain management, making it more efficient and reliable. The COVID-19 pandemic has also underscored the importance of agile and resilient supply chains, prompting greater investment in supply chain infrastructure. Additionally, the growing outsourcing trend among pharmaceutical companies to CROs for clinical trial logistics services is expanding market opportunities. Lastly, stringent regulatory requirements for clinical trial supplies are driving the adoption of comprehensive logistics solutions to ensure compliance and mitigate risks.

Select Competitors (Total 56 Featured) -

• Almac Group
• Bilcare Ltd.
• Biocair International Ltd.
• Catalent, Inc.
• Eurofins Scientific SE
• Experic
• ICON plc
• Intertek Group PLC
• IQVIA Inc.
• Lonza Group Ltd.
• Movianto
• Oximio
• Parexel International (MA) Corporation
• PCI Pharma Services
• Piramal Pharma Solutions;

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.